• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

c-Src 介导的甲状腺激素受体相互作用蛋白 6(TRIP6)磷酸化促进破骨细胞封闭带的形成。

c-Src-mediated phosphorylation of thyroid hormone receptor-interacting protein 6 (TRIP6) promotes osteoclast sealing zone formation.

机构信息

Department of Physiology and Cell Biology, The Ohio State University College of Medicine, Columbus, Ohio 43210, USA.

出版信息

J Biol Chem. 2010 Aug 20;285(34):26641-51. doi: 10.1074/jbc.M110.119909. Epub 2010 Jun 14.

DOI:10.1074/jbc.M110.119909
PMID:20547766
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2924104/
Abstract

Osteoclasts resorb bone through the formation of a unique attachment structure called the sealing zone. In this study, a role for thyroid hormone receptor-interacting protein 6 (TRIP6) in sealing zone formation and osteoclast activity was examined. TRIP6 was shown to reside in the sealing zone through its association with tropomyosin 4, an actin-binding protein that regulates sealing dimensions and bone resorptive capacity. Suppression of TRIP6 in mature osteoclasts by RNA interference altered sealing zone dimensions and inhibited bone resorption, whereas overexpression of TRIP6 increased the sealing zone perimeter and enhanced bone resorption. Treatment of osteoclasts with lysophosphatidic acid (LPA), which phosphorylates TRIP6 at tyrosine 55 through a c-Src-dependent mechanism, caused increased association of TRIP6 with the sealing zone, as did overexpression of a TRIP6 cDNA bearing a phosphomimetic mutation at tyrosine 55. Further, LPA treatment caused increases in osteoclast fusion, sealing zone perimeter, and bone resorptive capacity. In contrast, overexpression of TRIP6 containing a nonphosphorylatable amino acid residue at position 55 severely diminished sealing zone formation and bone resorption and suppressed the effects of LPA on the cytoskeleton. LPA effects were mediated through its receptor isoform LPA(2), as indicated by treatments with receptor-specific agonists and antagonists. Thus, these studies suggest that TRIP6 is a critical downstream regulator of c-Src signaling and that its phosphorylation is permissive for its presence in the sealing zone where it plays a positive role in osteoclast bone resorptive capacity.

摘要

破骨细胞通过形成一种独特的附着结构——封闭区来吸收骨骼。在这项研究中,研究了甲状腺激素受体相互作用蛋白 6(TRIP6)在封闭区形成和破骨细胞活性中的作用。研究表明,TRIP6 通过与肌球蛋白 4 结合而存在于封闭区中,肌球蛋白 4 是一种肌动蛋白结合蛋白,可调节封闭区的大小和骨吸收能力。通过 RNA 干扰抑制成熟破骨细胞中的 TRIP6 会改变封闭区的大小并抑制骨吸收,而过表达 TRIP6 会增加封闭区的周长并增强骨吸收。溶血磷脂酸(LPA)处理破骨细胞,通过 c-Src 依赖性机制使 TRIP6 酪氨酸 55 磷酸化,会导致 TRIP6 与封闭区的结合增加,而过表达含有酪氨酸 55 磷酸模拟突变的 TRIP6 cDNA 也会导致这种情况。此外,LPA 处理会导致破骨细胞融合、封闭区周长和骨吸收能力增加。相比之下,在位置 55 处含有不可磷酸化氨基酸残基的 TRIP6 的过表达严重削弱了封闭区的形成和骨吸收,并抑制了 LPA 对细胞骨架的作用。LPA 的作用是通过其受体亚型 LPA(2)介导的,这是通过使用受体特异性激动剂和拮抗剂进行治疗来表明的。因此,这些研究表明 TRIP6 是 c-Src 信号的关键下游调节剂,其磷酸化使其能够存在于封闭区中,在那里它在破骨细胞的骨吸收能力中发挥积极作用。

相似文献

1
c-Src-mediated phosphorylation of thyroid hormone receptor-interacting protein 6 (TRIP6) promotes osteoclast sealing zone formation.c-Src 介导的甲状腺激素受体相互作用蛋白 6(TRIP6)磷酸化促进破骨细胞封闭带的形成。
J Biol Chem. 2010 Aug 20;285(34):26641-51. doi: 10.1074/jbc.M110.119909. Epub 2010 Jun 14.
2
TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor.TRIP6通过与溶血磷脂酸2受体相互作用增强溶血磷脂酸诱导的细胞迁移。
J Biol Chem. 2004 Mar 12;279(11):10459-68. doi: 10.1074/jbc.M311891200. Epub 2003 Dec 18.
3
TRIP6: an adaptor protein that regulates cell motility, antiapoptotic signaling and transcriptional activity.TRIP6:一种衔接蛋白,调节细胞运动、抗凋亡信号和转录活性。
Cell Signal. 2011 Nov;23(11):1691-7. doi: 10.1016/j.cellsig.2011.06.004. Epub 2011 Jun 13.
4
c-Src-mediated phosphorylation of TRIP6 regulates its function in lysophosphatidic acid-induced cell migration.c-Src介导的TRIP6磷酸化调控其在溶血磷脂酸诱导的细胞迁移中的功能。
Mol Cell Biol. 2005 Jul;25(14):5859-68. doi: 10.1128/MCB.25.14.5859-5868.2005.
5
PTPL1/FAP-1 negatively regulates TRIP6 function in lysophosphatidic acid-induced cell migration.PTPL1/FAP-1在溶血磷脂酸诱导的细胞迁移中负向调节TRIP6的功能。
J Biol Chem. 2007 Aug 17;282(33):24381-7. doi: 10.1074/jbc.M701499200. Epub 2007 Jun 25.
6
Phosphorylation of a Wiscott-Aldrich syndrome protein-associated signal complex is critical in osteoclast bone resorption.威斯科特-奥尔德里奇综合征蛋白相关信号复合物的磷酸化在破骨细胞骨吸收中起关键作用。
J Biol Chem. 2007 Mar 30;282(13):10104-10116. doi: 10.1074/jbc.M608957200. Epub 2007 Feb 5.
7
Lysophosphatidic acid 2 receptor-mediated supramolecular complex formation regulates its antiapoptotic effect.溶血磷脂酸2受体介导的超分子复合物形成调节其抗凋亡作用。
J Biol Chem. 2009 May 22;284(21):14558-71. doi: 10.1074/jbc.M900185200. Epub 2009 Mar 17.
8
The adaptor protein TRIP6 antagonizes Fas-induced apoptosis but promotes its effect on cell migration.衔接蛋白 TRIP6 拮抗 Fas 诱导的细胞凋亡,但促进其对细胞迁移的作用。
Mol Cell Biol. 2010 Dec;30(23):5582-96. doi: 10.1128/MCB.00134-10. Epub 2010 Sep 27.
9
PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase.破骨细胞中的PYK2是一种黏附激酶,定位于封闭区,通过α(v)β3整合素的连接而激活,并被src激酶磷酸化。
J Clin Invest. 1998 Sep 1;102(5):881-92. doi: 10.1172/JCI3212.
10
Apatite-mediated actin dynamics in resorbing osteoclasts.磷灰石介导的破骨细胞吸收过程中的肌动蛋白动力学
Mol Biol Cell. 2004 Dec;15(12):5231-41. doi: 10.1091/mbc.e04-06-0522. Epub 2004 Sep 15.

引用本文的文献

1
Exogenous activation of the adhesion GPCR ADGRD1/GPR133 protects against bone loss by negatively regulating osteoclastogenesis.粘附GPCR ADGRD1/GPR133的外源性激活通过负向调节破骨细胞生成来预防骨质流失。
Sci Adv. 2025 Jul 11;11(28):eads3829. doi: 10.1126/sciadv.ads3829.
2
Itaconate is a metabolic regulator of bone formation in homeostasis and arthritis.衣康酸是维持骨稳态和关节炎中骨形成的代谢调节剂。
Ann Rheum Dis. 2024 Oct 21;83(11):1465-1479. doi: 10.1136/ard-2023-224898.
3
Autotaxin/Lysophosphatidic Acid Axis: From Bone Biology to Bone Disorders.自主分泌酶/溶血磷脂酸轴:从骨生物学到骨疾病。
Int J Mol Sci. 2022 Mar 22;23(7):3427. doi: 10.3390/ijms23073427.
4
Recent Advances in Osteoclast Biological Behavior.破骨细胞生物学行为的最新进展
Front Cell Dev Biol. 2021 Dec 8;9:788680. doi: 10.3389/fcell.2021.788680. eCollection 2021.
5
[Research progress on the biological regulatory function of lysophosphatidic acid in bone tissue cells].[溶血磷脂酸在骨组织细胞中的生物学调控功能研究进展]
Hua Xi Kou Qiang Yi Xue Za Zhi. 2020 Jun 1;38(3):324-329. doi: 10.7518/hxkq.2020.03.017.
6
Osteoclast-Derived Autotaxin, a Distinguishing Factor for Inflammatory Bone Loss.破骨细胞衍生的自分泌运动因子,炎症性骨丢失的鉴别因素。
Arthritis Rheumatol. 2019 Nov;71(11):1801-1811. doi: 10.1002/art.41005. Epub 2019 Sep 30.
7
Osteoblast-osteoclast interactions.成骨细胞-破骨细胞相互作用。
Connect Tissue Res. 2018 Mar;59(2):99-107. doi: 10.1080/03008207.2017.1290085. Epub 2017 Mar 21.
8
LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption.LGR4 是 RANKL 的受体,负向调节破骨细胞分化和骨吸收。
Nat Med. 2016 May;22(5):539-46. doi: 10.1038/nm.4076. Epub 2016 Apr 11.
9
The RhoGAP activity of myosin IXB is critical for osteoclast podosome patterning, motility, and resorptive capacity.肌球蛋白IXB的RhoGAP活性对于破骨细胞的小体模式、运动能力和吸收能力至关重要。
PLoS One. 2014 Jan 23;9(1):e87402. doi: 10.1371/journal.pone.0087402. eCollection 2014.
10
Lysophosphatidic acid receptor type 1 (LPA1) plays a functional role in osteoclast differentiation and bone resorption activity.溶血磷脂酸受体 1 型(LPA1)在破骨细胞分化和骨吸收活性中发挥功能作用。
J Biol Chem. 2014 Mar 7;289(10):6551-6564. doi: 10.1074/jbc.M113.533232. Epub 2014 Jan 15.

本文引用的文献

1
Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts.癌 细 胞 表 达 的 自 动 血 栓 溶 酶 原 控 制 了 骨 转 移 在 小 鼠 中 的 形 成,通 过 磷 脂 酸 依 赖 性 激 活 破 骨 细 胞。
PLoS One. 2010 Mar 17;5(3):e9741. doi: 10.1371/journal.pone.0009741.
2
Myosin X regulates sealing zone patterning in osteoclasts through linkage of podosomes and microtubules.肌球蛋白 X 通过衔接足突和微管调节破骨细胞封闭带的形成。
J Biol Chem. 2010 Mar 26;285(13):9506-9515. doi: 10.1074/jbc.M109.017269. Epub 2010 Jan 17.
3
LPA receptors: subtypes and biological actions.LPA 受体:亚型与生物学作用。
Annu Rev Pharmacol Toxicol. 2010;50:157-86. doi: 10.1146/annurev.pharmtox.010909.105753.
4
Human Protein Reference Database and Human Proteinpedia as discovery tools for systems biology.人类蛋白质参考数据库和人类蛋白质百科全书作为系统生物学的发现工具。
Methods Mol Biol. 2009;577:67-79. doi: 10.1007/978-1-60761-232-2_6.
5
Lysophosphatidic acid 2 receptor-mediated supramolecular complex formation regulates its antiapoptotic effect.溶血磷脂酸2受体介导的超分子复合物形成调节其抗凋亡作用。
J Biol Chem. 2009 May 22;284(21):14558-71. doi: 10.1074/jbc.M900185200. Epub 2009 Mar 17.
6
Regulated proteolysis of nonmuscle myosin IIA stimulates osteoclast fusion.非肌肉肌球蛋白IIA的调控性蛋白水解刺激破骨细胞融合。
J Biol Chem. 2009 May 1;284(18):12266-75. doi: 10.1074/jbc.M808621200. Epub 2009 Mar 5.
7
Lysophosphatidic acid signaling promotes proliferation, differentiation, and cell survival in rat growth plate chondrocytes.溶血磷脂酸信号传导促进大鼠生长板软骨细胞的增殖、分化和细胞存活。
Biochim Biophys Acta. 2009 May;1793(5):836-46. doi: 10.1016/j.bbamcr.2009.01.020. Epub 2009 Feb 21.
8
TRIP6, a novel molecular partner of the MAGI-1 scaffolding molecule, promotes invasiveness.TRIP6是MAGI-1支架分子的一种新型分子伴侣,可促进侵袭性。
FASEB J. 2009 Mar;23(3):916-28. doi: 10.1096/fj.08-106344. Epub 2008 Nov 18.
9
Rho GTPases in osteoclasts: orchestrators of podosome arrangement.破骨细胞中的Rho GTP酶:足体排列的协调者
Eur J Cell Biol. 2008 Sep;87(8-9):469-77. doi: 10.1016/j.ejcb.2008.03.002. Epub 2008 Apr 23.
10
Tropomyosin 4 regulates adhesion structures and resorptive capacity in osteoclasts.原肌球蛋白4调节破骨细胞中的黏附结构和吸收能力。
Exp Cell Res. 2008 Feb 1;314(3):564-73. doi: 10.1016/j.yexcr.2007.10.018. Epub 2007 Nov 1.